Nitrilase mediated mild hydrolysis of a carbon-14 nitrile for the radiosynthesis of 4-(7-hydroxycarbamoyl-[1- C-heptanoyl]-oxy)-benzoic acid methyl ester, [ C]-SHP-141: a novel class I/II histone deacetylase (HDAC) inhibitor.

Journal of labelled compounds & radiopharmaceuticals
Authors
Keywords
Abstract

A strategy has been developed for the carbon-14 radiosynthesis of [ C]-SHP-141, a 4-(7-hydroxycarbamoyl-heptanoyloxy)-benzoic acid methyl ester derivative containing a terminal hydroxamic acid. The synthesis involved four radiochemical transformations. The key step in the radiosynthesis was the conversion of the 7-[ C]-cyano-heptanoic acid benzyloxyamide [ C]-4 directly into the carboxylic acid derivative, 7-benzyloxycarbamoyl-[ C]-heptanoic acid [ C]-8 using nitrilase-113 biocatalyst. The final step involved deprotection of the benzyloxy group using catalytic hydrogenation to facilitate the release of the hydroxamic acid without cleaving the phenoxy ester. [ C]-SHP-141 was isolated with a radiochemical purity of 90% and a specific activity of 190 μCi/mg from four radiochemical steps starting from potassium [ C]-cyanide in a radiochemical yield of 45%.

Year of Publication
2023
Journal
Journal of labelled compounds & radiopharmaceuticals
Date Published
04/2023
ISSN
1099-1344
DOI
10.1002/jlcr.4026
PubMed ID
37186406
Links